Premium
Ultragenyx Pharmaceutical Inc (0LIF)
LSE
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| BlackRock, Inc. | Institution | 7 299 214 | 7,43% | US$ 472,92M | 2026-03-31 |
| Vanguard Portfolio Management, LLC | Institution | 5 385 992 | 5,49% | US$ 348,96M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 5 021 441 | 5,11% | US$ 325,34M | 2026-03-31 |
| AQR Capital Management, LLC | Institution | 4 561 242 | 4,65% | US$ 295,52M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 4 189 831 | 4,27% | US$ 271,46M | 2026-03-31 |
| RTW Investments, LP | Institution | 3 648 795 | 3,72% | US$ 236,41M | 2026-03-31 |
| Sands Capital Management, LLC | Institution | 3 214 533 | 3,27% | US$ 208,27M | 2026-03-31 |
| Sofinnova Investments, Inc. | Institution | 3 145 888 | 3,20% | US$ 203,82M | 2026-03-31 |
| Dr. Emil Kakkis | Initiés | 2 754 764 | 2,81% | US$ 178,48M | 2026-04-16 |
| Wellington Management Group LLP | Institution | 2 640 812 | 2,69% | US$ 171,10M | 2026-03-31 |
| Bellevue Asset Management AG | Institution | 2 380 000 | 2,42% | US$ 154,20M | 2026-03-31 |
| Assenagon Asset Management S.A. | Institution | 2 257 671 | 2,30% | US$ 146,27M | 2026-03-31 |
| Two Sigma Investments, LP | Institution | 2 205 820 | 2,25% | US$ 142,92M | 2026-03-31 |
| Frontier Capital Management Co LLC | Institution | 2 191 182 | 2,23% | US$ 141,97M | 2026-03-31 |
| Citadel Advisors LLC | Institution | 2 115 491 | 2,15% | US$ 137,06M | 2026-03-31 |
| Millennium Management LLC | Institution | 1 922 771 | 1,96% | US$ 124,58M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 1 849 391 | 1,88% | US$ 119,82M | 2026-03-31 |
| GW&K Investment Management, LLC | Institution | 1 615 426 | 1,65% | US$ 104,66M | 2026-03-31 |
| Jacobs Levy Equity Management Inc | Institution | 1 431 071 | 1,46% | US$ 92,72M | 2026-03-31 |
| Voloridge Investment Management, LLC | Institution | 1 426 834 | 1,45% | US$ 92,44M | 2026-03-31 |
| Norges Bank Investment Management | Institution | 1 261 026 | 1,28% | US$ 81,70M | 2025-12-31 |
| D. E. Shaw & Co., L.P. | Institution | 1 261 018 | 1,28% | US$ 81,70M | 2026-03-31 |
| Morgan Stanley | Institution | 1 222 951 | 1,25% | US$ 79,23M | 2026-03-31 |
| Rock Springs Capital Management LP | Institution | 1 218 773 | 1,24% | US$ 78,96M | 2026-03-31 |
| Jones Hill Capital LP | Institution | 1 165 557 | 1,19% | US$ 75,52M | 2026-03-31 |
| Candriam, Société En Commandite Par Actions | Institution | 1 096 182 | 1,12% | US$ 71,02M | 2026-03-31 |
| UBS Asset Management AG | Institution | 1 055 788 | 1,08% | US$ 68,40M | 2026-03-31 |
| Qube Research & Technologies Ltd | Institution | 914 760 | 0,93% | US$ 59,27M | 2026-03-31 |
| Point72 Asset Management, L.P. | Institution | 893 295 | 0,91% | US$ 57,88M | 2026-03-31 |
| Eagle Health Investments LP | Institution | 884 121 | 0,90% | US$ 57,28M | 2026-03-31 |
| Catalio Capital Management, LP | Institution | 850 797 | 0,87% | US$ 55,12M | 2026-03-31 |
| Sphera Funds Management Ltd | Institution | 809 333 | 0,82% | US$ 52,44M | 2026-03-31 |
| T. Rowe Price Group, Inc. | Institution | 804 109 | 0,82% | US$ 52,10M | 2026-03-31 |
| Bank of America Corporation | Institution | 764 012 | 0,78% | US$ 49,50M | 2026-03-31 |
| Teachers Insurance and Annuity Association-College Retirement Equities Fund | Institution | 625 276 | 0,64% | US$ 40,51M | 2026-03-31 |
| Hudson River Trading LLC | Institution | 613 229 | 0,62% | US$ 39,73M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
